Skip to main content
. 2016 Apr 20;11(6):3882–3888. doi: 10.3892/ol.2016.4485

Figure 4.

Figure 4.

Kaplan-Meier estimates of PSA failure-free survival based on the primary Gleason pattern in the biopsy GS 7 group within the intermediate-risk group (P=0.030; degrees of freedom=1). PSA, prostate-specific antigen; GS, Gleason score.